CLINICAL TRIALS PROFILE FOR TELOTRISTAT ETHYL
✉ Email this page to a colleague
Clinical Trials for Telotristat ethyl
| Trial ID | Title | Status | Sponsor | Phase | Summary |
|---|---|---|---|---|---|
| NCT03302845 ↗ | A Phase 1 Study to Evaluate the Effects of Omeprazole and Famotidine on the Absorption of Telotristat Ethyl in Healthy Subjects | Completed | Lexicon Pharmaceuticals | Phase 1 | This drug-drug interaction study will evaluate the impact of two different acid reducing agents (from two different drug classes) co-administered with a single dose of telotristat ethyl. |
| NCT03423446 ↗ | Study to Evaluate the Pharmacokinetics of Telotristat Ethyl in Subjects With Severe Hepatic Impairment | Completed | Lexicon Pharmaceuticals | Phase 1 | This study is designed to evaluate the effect of severe hepatic impairment on the pharmacokinetics (PK) of telotristat ethyl (TE) ( LP-778902 active moiety, metabolite), following administration of a single dose of TE 250 mg (1 x 250-mg tablet) compared to healthy, demographically-matched subjects with normal hepatic function. |
| NCT03790111 ↗ | A Safety and Efficacy Study of XERMELO® + First-line Chemotherapy in Patients With Advanced Biliary Tract Cancer | Active, not recruiting | Lexicon Pharmaceuticals | Phase 2 | A Phase 2, multicenter, open-label, 2-stage study to assess the safety, tolerability, and efficacy of XERMELO in combination with first-line (1L) therapy (cisplatin [cis] plus gemcitabine [gem]) |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Summary |
Clinical Trial Conditions for Telotristat ethyl
Condition Name
Clinical Trial Locations for Telotristat ethyl
Trials by Country
Clinical Trial Progress for Telotristat ethyl
Clinical Trial Phase
Clinical Trial Sponsors for Telotristat ethyl
Sponsor Name
